학술논문
Effect of adjuvant trastuzumab for a duration of 9 weeks vs 1 year with concomitant chemotherapy for early human epidermal growth factor receptor 2-positive breast cancer: The SOLD randomized clinical trial
Document Type
Conference Paper
Author
Joensuu, H.; Utriainen, M.; Halonen, P.; Fraser, J.; Ritchie, D.; Canney, P.; Wildiers, H.; Neven, P.; Huovinen, R.; Auvinen, P.; Nyandoto, P.; Villman, K.K.; Granstam-Björneklett, H.; Lundgren, L.; Sailas, L.; Turpeenniemi-Hujanen, T.; Tanner, M.; Kellokumpu-Lehtinen, P.-L.; Yachnin, J.; Johansson, O.; Huttunen, T.; Harvey, V.J.; Lindman, H.
Source
In: JAMA Oncology . (JAMA Oncology, September 2018, 4(9):1199-1206)
Subject
Language
English
ISSN
23742445
23742437
23742437